---
title: "Glooko, Inc. — Publisher Overview"
type: publisher
publisher: "Glooko, Inc."
publisher_slug: "glooko-inc"
canonical_url: "https://marlvel.ai/publishers/glooko-inc"
last_updated: 2026-05-08T03:18:03.537Z
source: Marlvel.ai
license: CC-BY-NC-4.0
citation: "Marlvel.ai — Glooko, Inc. Publisher Overview"
---
## ⚠ Content Warning

This publisher's portfolio includes apps classified as sensitive (health). Information is aggregated from public sources for informational purposes only. This overview touches health-related apps. It is not medical advice.

---

# Glooko, Inc. — Publisher Overview

> Enabling comprehensive diabetes management by aggregating data from medical devices and lifestyle trackers. Supporting patients and providers with centralized health insights.

- **Publisher:** Glooko, Inc.
- **Website:** [https://www.glooko.com](https://www.glooko.com)
- **Overview generated:** 2026-05-08
- **License:** CC-BY-NC 4.0

## Executive summary

Glooko operates as a specialized medical data aggregator, distinguishing itself through deep interoperability with over 200 distinct blood glucose meters, insulin pumps, and continuous glucose monitors. Their strategic moat is built on institutional-grade compliance, specifically FDA Part 11 and HIPAA, which allows them to bridge the gap between patient-generated lifestyle data and clinical research requirements. By positioning their platform as a neutral ecosystem for both individual health tracking and clinical trial support, they have successfully integrated into the professional care continuum rather than remaining a siloed consumer utility.

## Publisher DNA

- **Primary focus:** Medical data management and diabetes tracking
- **Scale:** indie
- **Target audience:** Individuals with diabetes managing chronic health metrics and healthcare professionals requiring integrated patient data for clinical oversight.

## Portfolio momentum

- **Velocity:** active
- **Active apps:** 2
- **Abandoned apps:** 0
- **Last major release:** 16 days ago

Released 8 updates across 2 apps in the last 6 months, maintaining consistent development activity for their core medical platforms.

## Aggregated portfolio metrics

- **Total reviews (all apps):** 8,824
- **Weighted rating:** 4.65 / 5
- **Apps in portfolio:** 2

## Category breakdown

| Category | Apps | Share |
| :--- | :--- | :--- |
| Medical | 2 | 100% |

## Top apps

- **Glooko - Track Diabetes Data** — Flagship platform with 8,820 reviews and multi-device integration.
- **Glooko Research** — Specialized ecosystem for clinical research and HIPAA-compliant data analytics.

## Signature patterns

- Centralized aggregation of data from a wide range of third-party medical hardware
- Focus on remote care collaboration between patients and clinical teams
- Strict adherence to medical data privacy and compliance standards
- Free-to-access model for both patient and research-focused applications

## Bottom line

Glooko is a highly specialized player that has successfully moved beyond simple tracking to become a critical data bridge in the diabetes care ecosystem. Their focus on device-agnostic integration provides a defensible position in a fragmented medical technology market.

---
© 2026 Marlvel.ai | [Publisher apps index](https://marlvel.ai/api/llm/publishers/glooko-inc) | [Methodology](https://marlvel.ai/api/llm/methodology)
Data licensed under CC-BY-NC 4.0.

---
© 2026 Marlvel.ai | [Full publisher profile](https://marlvel.ai/publishers/glooko-inc) | [Publisher apps index](https://marlvel.ai/api/llm/publishers/glooko-inc) | [Methodology](https://marlvel.ai/api/llm/methodology)
Data licensed under CC-BY-NC 4.0.